BMD
ANIK icon

Better Money Decisions’s Anika Therapeutics ANIK Stock Holding History

Better Money Decisions’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-43
Closed -$2K – 93
2021
Q3 		$2K Hold
43
– – ﹤0.01% 586
2021
Q2 		$2K Hold
43
– – ﹤0.01% 580
2021
Q1 		$2K Buy
+43
New +$1.63K ﹤0.01% 534

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Better Money Decisions's ANIK Position: Q4 2021 in Review

Better Money Decisions sold out of Anika Therapeutics (ANIK) in Q4 2021, closing a stake of 43 shares — an estimated $2K sold.

Better Money Decisions first reported a position in ANIK in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 126 funds tracked by Wall St. Rank hold ANIK as of Q4 2021.

  • Better Money Decisions reported no remaining Anika Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Better Money Decisions sold 43 Anika Therapeutics shares in Q4 2021, an estimated $2K.
  • Better Money Decisions first reported a position in Anika Therapeutics in Q1 2021 and held it in 3 quarters.
  • Better Money Decisions's Anika Therapeutics position peaked at $2K in Q3 2021.
  • 126 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2021.

Based on Better Money Decisions's 13F filing for Q4 2021, filed 14 Feb 2022.